1 |
Wang L, Zhou L, Zhou Y, Liu L, Jiang W, Zhang H, Liu H. Necroptosis in Pulmonary Diseases: A New Therapeutic Target. Front Pharmacol 2021;12:737129. [PMID: 34594225 DOI: 10.3389/fphar.2021.737129] [Reference Citation Analysis]
|
2 |
Hao Q, Idell S, Tang H. M1 Macrophages Are More Susceptible to Necroptosis. J Cell Immunol 2021;3:97-102. [PMID: 33959729 DOI: 10.33696/immunology.3.084] [Reference Citation Analysis]
|
3 |
Yuk H, Abdullah M, Kim DH, Lee H, Lee SJ. Necrostatin-1 Prevents Ferroptosis in a RIPK1- and IDO-Independent Manner in Hepatocellular Carcinoma. Antioxidants (Basel) 2021;10:1347. [PMID: 34572979 DOI: 10.3390/antiox10091347] [Reference Citation Analysis]
|
4 |
Erdogmus Ozgen Z, Erdinc M, Kelle İ, Erdinc L, Nergiz Y. Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart. Hum Exp Toxicol 2022;41:9603271211066066. [PMID: 35137609 DOI: 10.1177/09603271211066066] [Reference Citation Analysis]
|
5 |
Khodayar MJ, Kalantari H, Khorsandi L, Ahangar N, Samimi A, Alidadi H. Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in mice. Mol Biol Rep 2021;48:4153-62. [PMID: 34032977 DOI: 10.1007/s11033-021-06428-4] [Reference Citation Analysis]
|